Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3426543
Max Phase: Preclinical
Molecular Formula: C20H14Cl2N4O2
Molecular Weight: 413.26
Molecule Type: Small molecule
Associated Items:
ID: ALA3426543
Max Phase: Preclinical
Molecular Formula: C20H14Cl2N4O2
Molecular Weight: 413.26
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1C[C@]2(C(=O)Nc3ccc(Cl)cc32)c2cnn(Cc3ccc(Cl)cc3)c2N1
Standard InChI: InChI=1S/C20H14Cl2N4O2/c21-12-3-1-11(2-4-12)10-26-18-15(9-23-26)20(8-17(27)25-18)14-7-13(22)5-6-16(14)24-19(20)28/h1-7,9H,8,10H2,(H,24,28)(H,25,27)/t20-/m1/s1
Standard InChI Key: YHTOAXKFMFDLOO-HXUWFJFHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 413.26 | Molecular Weight (Monoisotopic): 412.0494 | AlogP: 3.82 | #Rotatable Bonds: 2 |
Polar Surface Area: 76.02 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.53 | CX Basic pKa: 1.60 | CX LogP: 3.34 | CX LogD: 3.34 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.67 | Np Likeness Score: -1.01 |
1. Zou B, Chan WL, Ding M, Leong SY, Nilar S, Seah PG, Liu W, Karuna R, Blasco F, Yip A, Chao A, Susila A, Dong H, Wang QY, Xu HY, Chan K, Wan KF, Gu F, Diagana TT, Wagner T, Dix I, Shi PY, Smith PW.. (2015) Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors., 6 (3): [PMID:25878766] [10.1021/ml500521r] |
2. Behnam MA, Nitsche C, Boldescu V, Klein CD.. (2016) The Medicinal Chemistry of Dengue Virus., 59 (12): [PMID:26771861] [10.1021/acs.jmedchem.5b01653] |
Source(1):